Cost Per Response/Remission Across Biologics for the Treatment of Biologic Naïve Patients with Moderate-To-Severe Ulcerative Colitis from the Italian Healthcare Provider Perspective
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.959
https://www.valueinhealthjournal.com/article/S1098-3015(16)32325-7/fulltext
Title :
Cost Per Response/Remission Across Biologics for the Treatment of Biologic Naïve Patients with Moderate-To-Severe Ulcerative Colitis from the Italian Healthcare Provider Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32325-7&doi=10.1016/j.jval.2016.09.959
First page :
A512
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
905